Tenax Therapeutics (TENX) Long-Term Deferred Tax (2015 - 2023)
Tenax Therapeutics (TENX) posted quarterly Long-Term Deferred Tax of $36.8 million for Q4 2023, up 2.02% year-over-year from $36.1 million in Q4 2022, and up 2.02% on a QoQ basis from $36.1 million in Q4 2022.
Tenax Therapeutics (TENX) Long-Term Deferred Tax (2015 - 2023) Analysis & Trends
Tenax Therapeutics has reported Long-Term Deferred Tax for 9 years, with the latest figure at $36.8 million in Q4 2023.
- Long-Term Deferred Tax for Q4 2023 came in at $36.8 million, up 2.02% year-over-year; the trailing twelve-month figure through Dec 2023 was $36.8 million (up 2.02% YoY), and the FY2023 annual result was $36.8 million, up 2.02% from the prior year.
- Long-Term Deferred Tax grew to $36.8 million in Q4 2023, from $36.1 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $36.8 million in Q4 2023 and troughed at $34.9 million in Q4 2019.
- A 5-year average of $35.7 million and a median of $35.5 million in 2020 frame the typical range for Long-Term Deferred Tax.
- The widest annual swing landed in 2019, when Long-Term Deferred Tax advanced 4.96%; it then retreated 0.7% in 2021.
- A 5-year view of Long-Term Deferred Tax shows it stood at $34.9 million in 2019, then climbed by 1.74% to $35.5 million in 2020, then slipped by 0.7% to $35.3 million in 2021, then advanced by 2.31% to $36.1 million in 2022, then grew by 2.02% to $36.8 million in 2023.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $36.8 million in Q4 2023, $36.1 million in Q4 2022, and $35.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 36.84 Mn |
| Dec 31, 2022 | 36.11 Mn |
| Dec 31, 2021 | 35.29 Mn |
| Dec 31, 2020 | 347.00 |
| Dec 31, 2019 | 34.93 Mn |
| Dec 31, 2018 | 33.28 Mn |
| Dec 31, 2017 | 32.24 Mn |
| Dec 31, 2016 | 56,180.00 |
| Dec 31, 2015 | 39.19 Mn |